|1.||Peschel, Andreas: 5 articles (11/2009 - 08/2003)|
|2.||Kristian, Sascha A: 5 articles (11/2009 - 08/2003)|
|3.||Weidenmaier, Christopher: 3 articles (05/2005 - 11/2003)|
|4.||Holst, Otto: 2 articles (08/2012 - 07/2006)|
|5.||Nizet, Victor: 2 articles (11/2009 - 08/2003)|
|6.||Landmann, Regine: 2 articles (11/2009 - 08/2003)|
|7.||Neumeister, Birgid: 2 articles (03/2004 - 08/2003)|
|8.||Rauch, Cyril: 1 article (04/2015)|
|9.||Leigh, James: 1 article (04/2015)|
|10.||Garmanchuk, L V: 1 article (11/2014)|
01/01/1982 - "The aim of this work was to study the effect of autolysis regulators (the fraction of microbial teichoic acids) on the rate of autolysis and the activity of bacterial extracellular lytic enzymes. "
07/01/2006 - "The aim of the present study was to evaluate the effect of d-alanine esters of teichoic acids on biofilm production and adhesion, autolysis, antimicrobial peptide sensitivity, and opsonic killing. "
07/01/1999 - "For instance, phage receptor activity relates to the presence of specific substituents on teichoic acids and polysaccharides; resistance to stress (UV radiation, acidic pH) depends on genes involved in peptidoglycan and teichoic acid biosynthesis; autolysis is controlled by the degree of esterification of teichoic acids with D-alanine; mucosal immunostimulation may result from interactions between epithelial cells and peptidoglycan or teichoic acids."
07/01/2000 - "Phosphocholine of pneumococcal teichoic acids: role in bacterial physiology and pneumococcal infection."
07/01/2004 - "Differences in clinical manifestation of Streptococcus pneumoniae infection are not correlated with in vitro production and release of the virulence factors pneumolysin and lipoteichoic and teichoic acids."
05/01/1989 - "Recent studies indicate that antibodies to cell wall antigens, including pneumococcal surface protein A and the phosphocholine (PC) determinant of teichoic acids as well as human C-reactive protein (which also binds to PC), can protect mice against pneumococcal infection. "
08/15/2010 - "A mutation of dltA, which is responsible for the D-alanylation of teichoic acids, brought about an increase in the survival rate of adult flies that had received a septic infection with the bacteria. "
08/01/2003 - "aureus ATCC35556 (S.a.113) and its isogenic mutant expressing unalanylated teichoic acids (dlt(-)) were compared in a tissue cage infection model that used C57BL/6 wt and TLR2-deficient mice. "
08/01/2003 - "Alanylation of teichoic acids protects Staphylococcus aureus against Toll-like receptor 2-dependent host defense in a mouse tissue cage infection model."
06/01/2003 - "[Detection of antibodies against teichoic acids (Endo-Staph Teichoic Acid Antibody Test, Meridian Diagnostic) in deep Staphylococcus aureus infections]."
11/01/2003 - "Two of these mechanisms involving the transfer of D-alanine into teichoic acids and of L-lysine into phospholipids, respectively, have been identified and characterized in Staphylococcus aureus, a major human pathogen in community- and hospital-acquired infections. "
05/15/2005 - "Lack of wall teichoic acids in Staphylococcus aureus leads to reduced interactions with endothelial cells and to attenuated virulence in a rabbit model of endocarditis."
06/01/1985 - "IgG antibody titers to all four teichoic acids in the 13 patients with Staphylococcus aureus endocarditis were significantly different from those in noninfected control patients (p less than 0.0001). "
01/01/1985 - "aureus teichoic acids and DNA in the sera of healthy donors and patients with infectious endocarditis and rheumatic carditis was made by means of ELISA. "
01/01/1982 - "Antibody responses against teichoic acids and other antigens from Staphylococcus aureus in 23 patients with septicemia and 8 patients with endocarditis caused by S. "
06/01/1985 - "An enzyme-linked immunosorbent assay (ELISA) for detection of IgG and IgM antibodies to cell-wall teichoic acids of Staphylococcus aureus and three defined coagulase-negative staphylococci was tested using serum samples from 11 cases of intravascular coagulase-negative staphylococcal infections, 13 cases of Staphylococcus aureus endocarditis, and 24 patients with no evidence of infection. "
|5.||Pneumococcal Meningitis (Streptococcus pneumoniae Meningitis)
02/01/2006 - "Experimentally, in Streptococcus pneumoniae meningitis, it has been shown that a vigorous inflammatory response to teichoic acids in the bacterial cell wall contributes to cochlear damage and subsequent fibrosis and ossification. "
09/01/1988 - "A diagnostic test for the detection of Streptococcus pneumoniae meningitis was developed using monoclonal antibodies (MAbs) to phosphocholine (PC) and non-PC determinants of pneumococcal teichoic acids. "
01/01/1999 - "In the rabbit model of Streptococcus pneumoniae meningitis, treatment with rifabutin, quinupristin-dalfopristin, moxifloxacin and trovafloxacin led to smaller increases of the CSF concentrations of the pro-inflammatory cell wall components lipoteichoic and teichoic acids (LTA and TA) than did treatment with ceftriaxone. "
|8.||pneumococcal surface protein A
|10.||Toll-Like Receptors (Toll-Like Receptor)